Nevertheless, despite the differences in clinical and immunoassay characteristics between cohorts, there were significant differences between COPD patients and controls for IL-6 and IL-8 in both cohorts, consistent with previous studies [302,303,304,305]. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.